New treatment for inflammatory bowel disease lands Microbiotica €42 million
UK biopharma Microbiotica announced the first close of a €42 million Series C led by British Business Bank with participation from Tencent, IP Group and others to develop precision microbiome medicines. Relevant as another European biotech growth round for benchmarking investor terms.